Valuation : Labcorp Holdings Inc.

Market Cap 26.04B 22.4B 21.13B 19.25B 35.99B 2,490B 36.31B 252B 96.86B 1,263B 97.79B 95.65B 4,011B P/E 2026 *
23x
P/E 2027 * 20.7x
Enterprise Value 31.19B 26.82B 25.31B 23.06B 43.1B 2,982B 43.49B 301B 116B 1,513B 117B 115B 4,804B EV / Sales 2026 *
2.11x
EV / Sales 2027 * 1.97x
Free-Float
99.65%
Yield 2026 *
0.91%
Yield 2027 * 0.92%
1 day-4.79%
1 week-7.22%
Current month-7.54%
1 month-4.27%
3 months+14.50%
6 months+14.47%
Current year+22.60%
1 week 305.45
Extreme 305.45
330.56
1 month 305.45
Extreme 305.45
341.8
Current year 245
Extreme 245
341.8
1 year 244.52
Extreme 244.52
341.8
3 years 191.97
Extreme 191.97
341.8
5 years 191.97
Extreme 191.97
341.8
10 years 98.02
Extreme 98.02
341.8
Date Insider Type Main position Quantity % Market Cap. Importance
9/1/26 A Free

Chief Technology Officer

3,000 0.0037%
9/1/26 A Free

Chief Technology Officer

750 0.0009%
9/1/26 A Free

EVP, COO

900 0.0011%
Change 5-day change 1-year change 3-year change Capi.($)
-4.39%-7.22%+12.69%+52.32% 26.04B
-1.20%-0.56%+91.91%+496.90% 47.61B
-0.67%+3.42%-14.67%-37.72% 6.95B
+4.85%+0.19%+4.82%+154.20% 5.58B
-0.16%+0.03%+20.70%+72.88% 3.37B
-1.81%-3.55%-31.58%+1,667.09% 2.58B
-0.45%+0.23%+133.96%+25.99% 2.27B
+12.37%+4.43%+33.52%+45.26% 2.17B
-2.03%-1.92%-19.22%-56.41% 1.81B
-0.01%+1.20%+38.19%+208.55% 1.62B
Average +0.56%+0.09%+27.03%+262.91% 10B
Weighted average by Cap. -1.53%+0.28%+50.24%+305.58%

Financials

2026 *2027 *
Net sales 14.75B 12.68B 11.97B 10.9B 20.38B 1,410B 20.57B 143B 54.86B 715B 55.39B 54.18B 2,272B 15.47B 13.31B 12.56B 11.44B 21.38B 1,479B 21.58B 150B 57.55B 750B 58.11B 56.84B 2,383B
Net income 1.13B 972M 917M 836M 1.56B 108B 1.58B 10.92B 4.2B 54.82B 4.24B 4.15B 174B 1.24B 1.07B 1.01B 918M 1.72B 119B 1.73B 12B 4.62B 60.24B 4.66B 4.56B 191B
Net Debt 5.15B 4.43B 4.18B 3.81B 7.12B 492B 7.18B 49.77B 19.16B 250B 19.34B 18.92B 793B 4.5B 3.87B 3.65B 3.33B 6.22B 430B 6.28B 43.51B 16.75B 218B 16.91B 16.54B 694B
Logo Labcorp Holdings Inc.
Labcorp Holdings Inc. provides comprehensive laboratory services that help doctors, hospitals, pharmaceutical companies, researchers and patients. The Company operates through two segments: Diagnostics Laboratories (Dx) and Biopharma Laboratory Services (BLS). The Diagnostics Laboratories segment includes routine testing and specialty/esoteric testing. Dx operates through a network of patient service centers, branches, rapid response laboratories, primary laboratories, and specialty laboratories. The BLS segment provides drug development and CDx development solutions from early-stage research to clinical development, along with support for crop protection and chemical testing, through its ED and Central Laboratory Services businesses. Its service also includes ambulatory outpatient laboratory services. The Company is focused on four primary specialty testing areas, such as oncology, women's health, autoimmune disease, and neurology.
Employees
66,385
Date Price Change Volume
10/09/26 $306.11 -4.67% 861,543
09/09/26 $321.10 -1.16% 960,238
08/09/26 $324.86 -0.62% 615,723
04/09/26 $326.89 -1.39% 438,651
03/09/26 $331.50 -0.05% 520,645
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
18
Last Close Price
321.10USD
Average target price
341.50USD
Spread / Average Target
+6.35%

Quarterly revenue - Rate of surprise

40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!